SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-031158
Filing Date
2024-08-12
Accepted
2024-08-12 08:01:42
Documents
53
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1022694
2 ex31-1.htm EX-31.1 20594
3 ex31-2.htm EX-31.2 21222
4 ex32-1.htm EX-32.1 8242
5 ex32-2.htm EX-32.2 8419
  Complete submission text file 0001493152-24-031158.txt   3576883

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE indp-20240630.xsd EX-101.SCH 22887
7 XBRL CALCULATION FILE indp-20240630_cal.xml EX-101.CAL 38765
8 XBRL DEFINITION FILE indp-20240630_def.xml EX-101.DEF 63967
9 XBRL LABEL FILE indp-20240630_lab.xml EX-101.LAB 255028
10 XBRL PRESENTATION FILE indp-20240630_pre.xml EX-101.PRE 198168
55 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 322132
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40652 | Film No.: 241194787
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)